CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Biotage - BIOT CFD

    120.4
    3.06%
    1.8
    Low: 119
    High: 124.1
    Market Trading Hours* (UTC) Opens on Tuesday at 08:00

    Mon - Fri: 08:00 - 16:25

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 1.8
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021948 %
    Charges from full value of position ($-4.17)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021948%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000275 %
    Charges from full value of position ($-0.05)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000275%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency SEK
    Margin 5%
    Stock exchange Sweden
    Commission on trade 0%

    *Information provided by Capital.com

    Biotage AB ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 124.2
    Open* 121.5
    1-Year Change* -33.02%
    Day's Range* 119 - 124.1
    52 wk Range 83.05-199.30
    Average Volume (10 days) 188.37K
    Average Volume (3 months) 5.14M
    Market Cap 10.11B
    P/E Ratio 46.26
    Shares Outstanding 80.01M
    Revenue 1.60B
    EPS 2.73
    Dividend (Yield %) 1.26683
    Beta 1.20
    Next Earnings Date Feb 15, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 124.2 3.6 2.99% 120.6 126.8 120.5
    Dec 7, 2023 122.8 -0.9 -0.73% 123.7 124.1 119.9
    Dec 6, 2023 125.4 3.4 2.79% 122.0 125.5 120.1
    Dec 5, 2023 121.1 0.3 0.25% 120.8 122.3 118.7
    Dec 4, 2023 121.2 -1.6 -1.30% 122.8 124.7 120.1
    Dec 1, 2023 122.8 -2.8 -2.23% 125.6 130.2 122.8
    Nov 30, 2023 131.2 3.9 3.06% 127.3 131.2 125.2
    Nov 29, 2023 129.4 5.9 4.78% 123.5 129.6 123.5
    Nov 28, 2023 126.5 1.8 1.44% 124.7 127.6 122.7
    Nov 27, 2023 124.5 -1.3 -1.03% 125.8 127.6 124.0
    Nov 24, 2023 128.0 1.7 1.35% 126.3 128.0 124.5
    Nov 23, 2023 126.2 0.9 0.72% 125.3 126.6 123.9
    Nov 22, 2023 125.4 3.5 2.87% 121.9 126.3 121.9
    Nov 21, 2023 121.8 -2.5 -2.01% 124.3 127.1 121.0
    Nov 20, 2023 124.4 -2.9 -2.28% 127.3 130.0 123.3
    Nov 17, 2023 127.2 9.7 8.26% 117.5 127.4 117.5
    Nov 16, 2023 121.3 2.6 2.19% 118.7 121.4 116.5
    Nov 15, 2023 118.7 -0.4 -0.34% 119.1 124.3 117.5
    Nov 14, 2023 118.7 0.5 0.42% 118.2 121.3 116.6
    Nov 13, 2023 118.7 -1.1 -0.92% 119.8 123.4 118.3

    Biotage Events

    Time (UTC) Country Event
    Thursday, February 15, 2024

    Time (UTC)

    14:00

    Country

    SE

    Event

    Q4 2023 Biotage AB Earnings Call
    Q4 2023 Biotage AB Earnings Call

    Forecast

    -

    Previous

    -
    Thursday, April 25, 2024

    Time (UTC)

    10:59

    Country

    SE

    Event

    Q1 2024 Biotage AB Earnings Release
    Q1 2024 Biotage AB Earnings Release

    Forecast

    -

    Previous

    -
    Friday, April 26, 2024

    Time (UTC)

    15:00

    Country

    SE

    Event

    Biotage AB Annual Shareholders Meeting
    Biotage AB Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1566 1232 1092.28 1101.37 910.896
    Revenue 1566 1232 1092.28 1101.37 910.896
    Cost of Revenue, Total 618 477 425.55 415.963 354.27
    Gross Profit 948 755 666.728 685.41 556.626
    Total Operating Expense 1239 961 886.093 893.253 738.418
    Selling/General/Admin. Expenses, Total 481 374 336.94 360.028 313.127
    Research & Development 68 56 44.102 49.733 43.101
    Depreciation / Amortization 89 65 66.449 65.132 34.032
    Interest Expense (Income) - Net Operating -35 -16 -19.352 -2.41 -14.681
    Unusual Expense (Income) 2.5 2.5
    Other Operating Expenses, Total 18 5 32.404 2.307 6.069
    Operating Income 327 271 206.185 208.12 172.478
    Interest Income (Expense), Net Non-Operating -7 -12 -8.901 3.949 3.811
    Other, Net 28 10 25.445 -0.077 0
    Net Income Before Taxes 348 269 222.729 211.992 176.289
    Net Income After Taxes 268 205 175.331 186.82 167.627
    Net Income Before Extra. Items 268 205 175.331 186.82 167.627
    Net Income 268 205 175.331 186.82 167.627
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items 268 205 175.331 186.82 167.627
    Income Available to Common Incl. Extra. Items 268 205 175.331 186.82 167.627
    Diluted Net Income 268 205 175.331 186.82 167.627
    Diluted Weighted Average Shares 66.1843 65.4648 65.2085 65.1821 64.7144
    Diluted EPS Excluding Extraordinary Items 4.0493 3.13145 2.68877 2.86612 2.59026
    Dividends per Share - Common Stock Primary Issue 1.6 1.55 1.5 0 1.5
    Diluted Normalized EPS 4.29365 3.17802 2.68877 2.89992 2.62699
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total revenue 449 409 361 384 401
    Revenue 449 409 361 384 401
    Cost of Revenue, Total 167 155 141 158 160
    Gross Profit 282 254 220 226 241
    Total Operating Expense 384 356 307 343 304
    Selling/General/Admin. Expenses, Total 169 143 126 150 127
    Research & Development 44 37 28 31 28
    Other Operating Expenses, Total 3 1 -1 4 -11
    Operating Income 65 53 54 41 97
    Interest Income (Expense), Net Non-Operating -19 -9 2 55 -12
    Net Income Before Taxes 46 44 56 96 85
    Net Income After Taxes 38 34 43 74 65
    Net Income Before Extra. Items 38 34 43 74 65
    Net Income 38 34 43 74 65
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items 38 34 43 74 65
    Income Available to Common Incl. Extra. Items 38 34 43 74 65
    Diluted Net Income 38 34 43 74 65
    Diluted Weighted Average Shares 80.1183 69.5922 66.1808 66.2002 66.1946
    Diluted EPS Excluding Extraordinary Items 0.4743 0.48856 0.64974 1.11782 0.98195
    Dividends per Share - Common Stock Primary Issue 0 0 0 1.6 0
    Diluted Normalized EPS 0.54647 0.76615 0.85858 1.11782 0.98195
    Unusual Expense (Income) 1 20 13
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1031 774 751.615 586.569 494.438
    Cash and Short Term Investments 441 311 371.325 185.867 177.02
    Cash & Equivalents 441 311 371.325 185.867 177.02
    Total Receivables, Net 260 207 207.455 212.815 173.728
    Accounts Receivable - Trade, Net 223 180 194.018 197.651 156.042
    Total Inventory 305 237 159.823 173.76 132.338
    Prepaid Expenses 25 19 13.013 14.128 11.352
    Other Current Assets, Total -0.001 -0.001
    Total Assets 2339 1992 1434.44 1335.69 1003.2
    Property/Plant/Equipment, Total - Net 162 128 103.656 112.253 48.63
    Property/Plant/Equipment, Total - Gross 385 324 201.79 215.717 130.51
    Accumulated Depreciation, Total -223 -196 -98.134 -103.464 -81.88
    Goodwill, Net 794 741 290.209 315.869 186.055
    Intangibles, Net 308 313 250.787 260.047 192.654
    Long Term Investments 21 14 12.254 16.614 17.368
    Note Receivable - Long Term 0.003
    Other Long Term Assets, Total 23 22 25.92 44.335 64.055
    Total Current Liabilities 417 313 217.364 212.272 173.397
    Accounts Payable 57 56 51.236 41.461 54.764
    Payable/Accrued 0.001
    Accrued Expenses 58.479 69.334 60.411
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 25 23 21.214 21.231
    Other Current Liabilities, Total 335 234 86.435 80.245 58.222
    Total Liabilities 702 621 444.403 460.184 301.023
    Total Long Term Debt 192 180 140.677 147.647 109.4
    Deferred Income Tax 71 73 32.838 28.884 14.78
    Other Liabilities, Total 22 55 53.524 71.381 3.446
    Total Equity 1637 1371 990.038 875.503 702.18
    Common Stock 93 92 90.969 90.63 89.953
    Retained Earnings (Accumulated Deficit) 1229 1063 956.114 781.121 692.104
    Other Equity, Total 34 -50 -116.547 3.752 -79.877
    Total Liabilities & Shareholders’ Equity 2339 1992 1434.44 1335.69 1003.2
    Total Common Shares Outstanding 65.9838 65.9838 65.2018 64.7144 64.7144
    Long Term Debt 150 150 110 109.55 109.4
    Capital Lease Obligations 42 30 30.677 38.097
    Additional Paid-In Capital 281 266 59.502
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1379 1288 1034 1031 1008
    Cash and Short Term Investments 501 444 426 441 388
    Cash & Equivalents 501 444 426 441 388
    Total Receivables, Net 370 408 306 285 314
    Accounts Receivable - Trade, Net 279 308 229 223 253
    Total Inventory 508 436 302 305 306
    Other Current Assets, Total
    Total Assets 5001 5002 2362 2339 2306
    Property/Plant/Equipment, Total - Net 193 200 98 162 138
    Goodwill, Net 2491 2575 801 794 804
    Intangibles, Net 888 885 376 308 319
    Long Term Investments 19 20 20 21 15
    Other Long Term Assets, Total 31 34 33 23 22
    Total Current Liabilities 728 689 377 417 402
    Accounts Payable 174 139 64 57 74
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 30 22 23 25 23
    Other Current Liabilities, Total 524 528 290 335 305
    Total Liabilities 1311 1257 674 702 707
    Total Long Term Debt 221 196 196 192 174
    Long Term Debt 150 150 150 150 150
    Capital Lease Obligations 71 46 46 42 24
    Deferred Income Tax 202 212 86 71 73
    Other Liabilities, Total 160 160 15 22 58
    Total Equity 3690 3745 1688 1637 1599
    Common Stock 112 112 93 93 92
    Additional Paid-In Capital 2291 2289 282 281 277
    Retained Earnings (Accumulated Deficit) 1241 1199 1273 1229 1155
    Other Equity, Total 46 145 40 34 75
    Total Liabilities & Shareholders’ Equity 5001 5002 2362 2339 2306
    Total Common Shares Outstanding 80.0082 79.9379 65.9838 65.9838 65.9838
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 348 269 222.729 211.992 176.289
    Cash From Operating Activities 341 353 279.047 211.807 155.005
    Cash From Operating Activities 102 75 73.904 74.372 39.412
    Non-Cash Items -17 4 -11.661 2.129 -11.727
    Cash Taxes Paid 52 16 15.083 9.925 9.314
    Cash Interest Paid 5 3 3.339 2.86 1.738
    Changes in Working Capital -92 5 -5.925 -76.686 -48.969
    Cash From Investing Activities -84 -341 -61.32 -85.676 -178.411
    Capital Expenditures -70 -56 -60.941 -45.454 -47.158
    Other Investing Cash Flow Items, Total -14 -285 -0.379 -40.222 -131.253
    Cash From Financing Activities -133 -82 -22.723 -119.205 19.342
    Total Cash Dividends Paid -102 -98 0 -97.803 -90.6
    Issuance (Retirement) of Debt, Net -30 16 -22.723 -21.402 109.942
    Foreign Exchange Effects 7 9 -9.547 1.921 6.821
    Net Change in Cash 131 -61 185.457 8.847 2.757
    Financing Cash Flow Items -1
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 56 348 252 167 92
    Cash From Operating Activities 11 341 242 145 57
    Cash From Operating Activities 26 102 74 49 23
    Non-Cash Items -3 -17 28 23 5
    Cash Taxes Paid 39 52 38 27 15
    Changes in Working Capital -68 -92 -112 -94 -63
    Cash From Investing Activities -19 -84 -49 -32 -14
    Capital Expenditures -19 -70 -49 -31 -14
    Other Investing Cash Flow Items, Total 0 -14 0 -1 0
    Cash From Financing Activities -7 -133 -127 -119 -6
    Issuance (Retirement) of Debt, Net -7 -30 -25 -17 -6
    Foreign Exchange Effects 0 7 12 8 2
    Net Change in Cash -15 131 78 2 39
    Total Cash Dividends Paid 0 -102 -102 -102 0
    Financing Cash Flow Items -1
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Kohlberg Kravis Roberts & Co. L.P. Private Equity 16.85 13481379 13481379 2023-08-31 MED
    SEB Investment Management AB Investment Advisor 7.19 5752589 190157 2023-08-31 LOW
    Didner & Gerge Fonder AB Investment Advisor 5.1902 4152571 150000 2023-10-17 LOW
    Invesco Advisers, Inc. Investment Advisor 4.31 3448353 -32099 2023-08-31 LOW
    Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 4.22 3376345 -23874 2023-08-31 LOW
    ODIN Forvaltning AS Investment Advisor 3.7496 3000000 0 2023-09-30 LOW
    Fjärde AP-Fonden Pension Fund 3.37 2696276 10736 2023-08-31 LOW
    Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 3.2497 2600000 0 2023-09-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.96 2368242 39015 2023-08-31 LOW
    Lannebo Fonder AB Investment Advisor/Hedge Fund 2.7053 2164438 0 2022-12-31 LOW
    Första AP-Fonden Pension Fund 2.36 1888193 559480 2023-08-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.14 1712175 154251 2023-08-31 LOW
    Danske Bank Asset Management Investment Advisor 1.5507 1240672 30000 2023-09-30 LOW
    TIN Fonder Investment Advisor 1.4 1120115 100151 2023-08-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.39 1112114 -62397 2023-08-31 LOW
    Tredje AP Fonden Pension Fund 1.2969 1037604 -1033099 2023-06-30 MED
    Montanaro Asset Management Limited Investment Advisor 1.22 976100 72122 2023-08-31 LOW
    M&G Investment Management Ltd. Investment Advisor 1.2 960098 75915 2023-08-31 LOW
    Andra AP-Fonden Pension Fund 1.02 816083 -160477 2023-08-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1 800082 28072 2023-08-31 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Biotage Company profile

    Biotage is a Sweden-based Life Science company, specialising in separation and synthesis solutions. The company’s offering comprises three distinct product lines. The Organic Chemistry line seeks to rationalise the development of drugs by purifying substances that will become new drugs. The Analytical Chemistry line aims to reinvent the sample analysis. The Industrial Product line offers innovative systems and consumables that separate substances during the large-scale production. All product lines are available across Europe and the US by the Biotage sales organisation or by distributors. Headquartered in Uppsala, Sweden, Biotage trades on the NASDAQ Stockholm under the BIOT ticker. Find out the latest BIOT stock news at Capital.com.
    Industry: Medical Diagnostic & Testing Equipment

    Vimpelgatan 5
    UPPSALA
    UPPSALA 753 18
    SE

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    US100

    16,219.10 Price
    +0.880% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Gold

    1,981.42 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0201%
    Short position overnight fee 0.0118%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    BTC/USD

    40,845.85 Price
    -6.830% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.62 Price
    -7.230% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading